AMAG Pharmaceuticals, Inc. has made changes to its medical development organization. Effective March 31, 2020, Julie Krop, M.D., Executive Vice President and Chief Medical Officer, will be leaving the company. As AMAG initiates a search for a permanent Chief Medical Officer, the Board and management will continue to work closely with the medical development organization on key priorities, including working with the U.S. FDA to find a path to retain patient and provider access to Makena and advan...